Cargando…

Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

BACKGROUND: Whether factor V Leiden is associated with lower bleeding risk in patients with acute coronary syndromes using (dual) antiplatelet therapy has yet to be investigated. METHODS AND RESULTS: We pooled data from 3 randomized clinical trials, conducted in patients with acute coronary syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmoodi, Bakhtawar K., Eriksson, Niclas, Ross, Stephanie, Claassens, Daniel M. F., Asselbergs, Folkert W., Meijer, Karina, Siegbahn, Agneta, James, Stefan, Pare, Guillaume, Wallentin, Lars, ten Berg, Jurriën M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649290/ https://www.ncbi.nlm.nih.gov/pubmed/34459239 http://dx.doi.org/10.1161/JAHA.120.021115

Ejemplares similares

Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis
por: Mahmoodi, Bakhtawar K., et al.
Publicado: (2021)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome
por: Johansson, Åsa, et al.
Publicado: (2015)

Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐Analysis
por: Brouwer, Jorn, et al.
Publicado: (2021)

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
por: Attelind, Sofia, et al.
Publicado: (2022)

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
por: Al-Rubaish, Abdullah M., et al.
Publicado: (2020)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
por: Siegbahn, Agneta, et al.
Publicado: (2023)

Possible impact of factor V Leiden genotype on warfarin induced bleeding
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres
por: Janssen, P. W. A., et al.
Publicado: (2017)

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2020)

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
por: Bauer, Tim, et al.
Publicado: (2011)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
por: Wallentin, Lars, et al.
Publicado: (2021)

Wolfgang Pauli in Leiden
por: Unknown
Publicado: (1953)

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008)

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Ueland, Thor, et al.
Publicado: (2018)

Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
por: Oh, Hyoung-Chul, et al.
Publicado: (2018)

Genetic testing in antiplatelet therapy – not effective for perioperative bleeding
por: Kuliczkowski, Wiktor
Publicado: (2017)

Antiplatelets/enoxaparin-sodium: Major bleeding: case report
Publicado: (2020)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
por: Claassens, Daniel MF, et al.
Publicado: (2020)

Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice
por: Schilperoort, Maaike, et al.
Publicado: (2020)

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
por: Lindholm, Daniel, et al.
Publicado: (2017)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Apples in Amsterdam and oranges in Leiden
por: Koster, R. W.
Publicado: (2014)

Dual Antiplatelet Therapy and the Severity Risk of Lower Intestinal Bleeding
por: Carlin, Neal, et al.
Publicado: (2017)

Reversing Bleeding Associated With Antiplatelet Use: The Role of Tranexamic Acid
por: Fischer, Kyle, et al.
Publicado: (2020)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
por: Pasea, Laura, et al.
Publicado: (2017)

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
por: Wallentin, Lars, et al.
Publicado: (2013)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

Testing differences statistically with the Leiden ranking
por: Leydesdorff, Loet, et al.
Publicado: (2012)

Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi‐country observational study
por: Lesén, Eva, et al.
Publicado: (2021)

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
por: Pol, Tymon, et al.
Publicado: (2021)

Effects of Antiplatelet Agents on Bleeding after Endoscopic Resection of Gastric Tumor
por: Ahn, Ji Yong
Publicado: (2018)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
por: Tersalvi, Gregorio, et al.
Publicado: (2020)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
por: Godier, Anne, et al.
Publicado: (2020)

The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
por: Wang, Qi, et al.
Publicado: (2020)

Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk
por: Fuentes, Eduardo, et al.
Publicado: (2021)

Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis
por: Aljundi, Lamia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_676cl19gc9ho82mu9rfn0tvrfd